Trivium Point Advisory, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1766564 WILTON, CT

Position in GILD

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$898,403

+$15,216 QoQ

Shares Held

7,111

+12.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#1,122

of 2,266 holders

Holding Since

Jun 2022

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Trivium Point Advisory, LLC holds $28,456,605 across 8 Drug Manufacturers - General names. GILD ranks #8 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	13,340	$16,000,397
2	JNJ	Johnson & Johnson	12,027	$3,054,497
3	ABBV	AbbVie Inc.	10,728	$2,699,593
4	MRK	Merck & Co., Inc.	17,671	$2,270,723
5	AMGN	Amgen Inc	3,478	$1,259,453
6	BMY	Bristol Myers Squibb Co	20,481	$1,180,115
7	PFE	Pfizer Inc	45,408	$1,093,424
8	GILD	Gilead Sciences, Inc. This page	7,111	$898,403

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$898,403	7,111	+12.2%	Shares	Sole	2026-08-06
2026-03-31	$883,187	6,337	-14.7%	Shares	Sole	2026-04-21
2025-12-31	$911,835	7,429	+1.4%	Shares	Sole	2026-01-26
2025-09-30	$813,075	7,325	+1.1%	Shares	Sole	2025-11-12
2025-06-30	$802,920	7,242	+294.4%	Shares	Sole	2025-07-17
2025-03-31	$205,723	1,836	-49.7%	Shares	Sole	2025-05-13
2024-06-30	$250,289	3,648	-85.3%	Shares	Sole	2024-08-14
2023-12-31	$2,006,698	24,771	+2.2%	Shares	Sole	2024-02-05
2023-09-30	$1,816,395	24,238	+4.5%	Shares	Sole	2023-10-12
2023-06-30	$1,786,945	23,186	+7.0%	Shares	Sole	2023-07-13
2023-03-31	$1,798,125	21,672	+2.6%	Shares	Sole	2023-04-12
2022-12-31	$1,813,237	21,121	+15.8%	Shares	Sole	2023-01-27
2022-09-30	$1,125,534	18,245	+71.8%	Shares	Sole	2022-11-09
2022-06-30	$656,484	10,621	—	Shares	Sole	2022-07-27
No filing history on record for this holder in this stock.